CSI Market
Sign In | Register

Newamsterdam Pharma N v (NAMS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access NAMS Annual Balance Sheets →
A period-by-period view of the balance sheet from Newamsterdam Pharma N v to Mar 31 2025 helps clarify how Mar 31 2026's financial structure has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent457.61
Marketable Securities, Current SH178.50
Cash & Short-term Investments635.00
Other Receivables8.02
Notes Receivable, Current0.21
Other Current Assets1.34
Prepaid Expense And Other Assets Current2.27
Total Current Assets658.04
Equipment/Property/Plant Net0.38
Intangible Assets0.38
Long-term investments71.24
Tax Assets, Noncurrent0.00
Prepaid Expense, Noncurrent, Total PR2.59
Other Assets, Noncurrent10.13
Restricted Cash Current1.34
Operating Lease Right Of Use Asset0.02
Total Assets732.64
Liabilities
Accounts Payable, Current AC5.09
Accrued Liabilities, Current2.27
Derivative Liability, Current DE50.23
Other Liabilities, Current5.12
Deferred Revenue, Current DE3.99
Total Current Liabilities67.42
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Operating Lease Liability Current0.02
Operating Lease Liability Noncurrent-
Total Liabilities67.42
Stockholders' Equity
Common Stock Value14.59
Additional Paid In Capital Common Stock1,457.24
Retained Earnings / Accumulated Deficit-810.83
Accumulated Other Comprehensive Income4.22
Other Equity4.22
Common Stockholder's Equity665.22
Total Stockholder's Equity665.22
Liabilities & Stockholder's Equity732.64
4 historic quarters locked

Sign in to unlock the full Newamsterdam Pharma N v balance sheet history.

Sign In Create Free Account

About Newamsterdam Pharma Co N V Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-333824

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.